https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab The Life Sciences Lab blog covers topics of interest for the life sciences industry, specifically for in-house counsel, executives, researchers and other thought leaders in the pharmaceutical, medical device, and related fields.  Posts will be timely and topical for the life sciences industry, including but not limited to emerging technologies, new therapeutics, legislation, regulation, litigation trends, summaries of presentations and panels where Nelson Mullins life sciences attorneys have spoken.  https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/iarc-to-evaluate-key-plasticizers-for-carcinogenic-risk-in-june-2026 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/iarc-to-evaluate-key-plasticizers-for-carcinogenic-risk-in-june-2026 Thu, 31 Jul 2025 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/iarc-releases-its-priority-evaluation-list-for-2025-2029 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/iarc-releases-its-priority-evaluation-list-for-2025-2029 Wed, 11 Sep 2024 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/iarc-plans-evaluation-of-automotive-gasoline-and-oxygenated-additives-in-early-2025 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/iarc-plans-evaluation-of-automotive-gasoline-and-oxygenated-additives-in-early-2025 Tue, 03 Sep 2024 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/leveraging-federal-rule-of-evidence-806-to-uncover-bias-in-serial-tort-litigation https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/leveraging-federal-rule-of-evidence-806-to-uncover-bias-in-serial-tort-litigation Tue, 27 Aug 2024 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/how-companies-should-navigate-carcinogen-evaluations-by-research-organizations https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/how-companies-should-navigate-carcinogen-evaluations-by-research-organizations Wed, 21 Aug 2024 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/fda-publishes-paper-detailing-actions-it-intends-to-take-regarding-the-uses-of-ai-across-the-medical-product-life-cycle https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/fda-publishes-paper-detailing-actions-it-intends-to-take-regarding-the-uses-of-ai-across-the-medical-product-life-cycle Tue, 19 Mar 2024 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/hsu-untied-interview-with-jae-lee https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/hsu-untied-interview-with-jae-lee Mon, 19 Feb 2024 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/nelson-mullins-achieves-mansfield-certification https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/nelson-mullins-achieves-mansfield-certification Tue, 17 Oct 2023 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/two-new-fda-drug-supply-chain-security-act-guidances-to-help-pharmaceutical-supply-chain-partners-comply-with-the-dscsa-s-move-to-electronic-tracking https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/two-new-fda-drug-supply-chain-security-act-guidances-to-help-pharmaceutical-supply-chain-partners-comply-with-the-dscsa-s-move-to-electronic-tracking Thu, 31 Aug 2023 00:00:00 +0000 https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/nelson-mullins-partner-alana-bassin-named-product-liability-lawyer-of-the-year-at-2023-women-in-business-law-awards https://www.nelsonmullins.com/insights/blogs/the-life-sciences-lab/all/nelson-mullins-partner-alana-bassin-named-product-liability-lawyer-of-the-year-at-2023-women-in-business-law-awards Wed, 14 Jun 2023 00:00:00 +0000